133059-43-5

Basic information

• Product Name: 4-Bromo-3-fluorobenzaldehyde
• Synonyms: 4-BROMO-3-FLUOROBENZALDEHYDE;4-Bromo-3-fluorobenzaldehyde 98%;4-Bromo-3-fluorobenzaldehyde98%;3-Fluoro-4-bromobenzaldehyde;Benzaldehyde, 4-broMo-3-fluoro-;4-BroMo-3-fluorobenzaldehyde, 95+%;4 - broMine - 3 - fluoro benzaldehyde
• CAS NO: 133059-43-5
• Molecular Formula: C₇H₄BrFO
• Molecular Weight: 203.01
• Product Categories: Aromatic Aldehydes & Derivatives (substituted);Benzaldehyde;Miscellaneous;Aldehydes;Aryl Fluorinated Building Blocks;Building Blocks;C7;Carbonyl Compounds;Chemical Synthesis;Fluorinated Building Blocks;Organic Building Blocks;Organic Fluorinated Building Blocks;Other Fluorinated Organic Building Blocks
• Mol File: 133059-43-5.mol
• Article Data: 11

Chemical Properties

• Melting Point: 55-59℃
• Boiling Point: 240.2 °C at 760 mmHg
• Flash Point: 99.1 °C
• Appearance: /
• Density: 1.67 g/cm³
• Vapor Pressure: 0.0384mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Room temperature.
• Solubility: soluble in Methanol
• CAS DataBase Reference: 4-Bromo-3-fluorobenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-3-fluorobenzaldehyde(133059-43-5)
• EPA Substance Registry System: 4-Bromo-3-fluorobenzaldehyde(133059-43-5)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-36-22
• Safety Statements: 26-36/37/39
• WGK Germany: 3
• Hazardous Substances Data: 133059-43-5(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Uses

4-Bromo-3-fluorobenzaldehyde is used in preparation of the Deuterated Dihydropyrimidine compound and their application as anti-HBV agent.

InChI:InChI=1/C7H4BrFO/c8-6-2-1-5(4-10)3-7(6)9/h1-4H

Upstream product

• 124-38-9 carbon dioxide 
• 136434-77-0 4-bromo-3-fluoroiodobenzene 
• 201230-82-2 carbon monoxide 
• 127425-73-4 1-bromo-4-(bromomethyl)-2-fluorobenzene 
• 350587-20-1 1-bromo-4-(dibromomethyl)-2-fluorobenzene 
• 222978-01-0 4-bromo-3-fluorobenzyl alcohol 
• 133059-44-6 4-bromo-3-fluorobenzonitrile 

Downstream Products

• 350587-21-2 (+/-)-4-bromo-3-fluoro-1-(1-hydroxy-3-buten-1-yl)benzene 
• 923266-16-4 3-(4-bromo-3-fluoro-phenyl)-acrylic acid ethyl ester 
• 950691-70-0 1-bromo-4-(diethoxymethyl)-2-fluorobenzene 
• 950691-66-4 methyl 1-(4-bromo-3-fluorobenzyl)azetidine-3-carboxylate 
• 1365267-60-2 (Z)-5-(4-bromo-3-fluorobenzylidene)-4-thioxo-thiazolidine-2-one 
• 1415003-41-6 5-(4-bromo-3-fluorophenyl)pentanoic acid 
• 1415003-40-5 (E)-5-(4-bromo-3-fluorophenyl)pent-4-enoic acid 
• 1283119-15-2 methyl 2-fluoro-4-(2-oxo-5,6-diphenyl-1,2,3,4-tetrahydropyrimidin-4-yl)benzoate 

Related news

Analysis of 4-Bromo-3-fluorobenzaldehyde (cas 133059-43-5) and separation of its regioisomers by one-dimensional and two-dimensional gas chromatography09/02/2019

A starting material, 4-bromo-3-fluorobenzaldehyde, was used for active drug substance (API) AMG 369 production. The presence of the regioisomer impurities in the starting material 4-bromo-3-fluorobenzaldehyde presented significant challenges for the API synthetic route development due to the phy...detailed

Relevant articles and documents

Rhodium-catalyzed reductive carbonylation of aryl iodides to arylaldehydes with syngas

The reductive carbonylation of aryl iodides to aryl aldehydes possesses broad application prospects. We present an efficient and facile Rh-based catalytic system composed of the commercially available Rh salt RhCl3·3H2O, PPh3 as phosphine ligand, and Et3N as the base, for the synthesis of arylaldehydes via the reductive carbonylation of aryl iodides with CO and H2 under relatively mild conditions with a broad substrate range affording the products in good to excellent yields. Systematic investigations were carried out to study the experimental parameters. We explored the optimal ratio of Rh salt and PPh3 ligand, substrate scope, carbonyl source and hydrogen source, and the reaction mechanism. Particularly, a scaled-up experiment indicated that the catalytic method could find valuable applications in industrial productions. The low gas pressure, cheap ligand and low metal dosage could significantly improve the practicability in both chemical researches and industrial applications.

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS

This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.

REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE A AND B

The instant invention relates to compounds of formula I, diagrammed below, wherein R3, E, D and Y are defined in the application, which are useful as reversible inhibitors of monoamine oxidase-B and/or monoamine oxidase-A, and therefore useful to treat or prevent neurological diseases or conditions in mammals, preferably humans.